ATE549410T1 - Kontrollierte aktivierung von nicht-ltr- retrotransposonen bei säugetieren - Google Patents

Kontrollierte aktivierung von nicht-ltr- retrotransposonen bei säugetieren

Info

Publication number
ATE549410T1
ATE549410T1 AT08844540T AT08844540T ATE549410T1 AT E549410 T1 ATE549410 T1 AT E549410T1 AT 08844540 T AT08844540 T AT 08844540T AT 08844540 T AT08844540 T AT 08844540T AT E549410 T1 ATE549410 T1 AT E549410T1
Authority
AT
Austria
Prior art keywords
mammals
controlled activation
ltr retrotransposons
retrotransposons
ltr
Prior art date
Application number
AT08844540T
Other languages
English (en)
Inventor
Gerald Schumann
Liliana Layer
Original Assignee
Bundesrepublik Deutschland Letztvertreten Durch Den Praesidenten Des Paul Ehrlich Inst Prof Dr Klaus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bundesrepublik Deutschland Letztvertreten Durch Den Praesidenten Des Paul Ehrlich Inst Prof Dr Klaus filed Critical Bundesrepublik Deutschland Letztvertreten Durch Den Praesidenten Des Paul Ehrlich Inst Prof Dr Klaus
Application granted granted Critical
Publication of ATE549410T1 publication Critical patent/ATE549410T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/24—Vectors characterised by the absence of particular element, e.g. selectable marker, viral origin of replication
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08844540T 2007-10-31 2008-10-30 Kontrollierte aktivierung von nicht-ltr- retrotransposonen bei säugetieren ATE549410T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07021311A EP2055784A1 (de) 2007-10-31 2007-10-31 Kontrollierte Aktivierung von Nicht-LTR-Retrotransposonen bei Säugetieren
PCT/EP2008/009179 WO2009056321A1 (en) 2007-10-31 2008-10-30 Controlled activation of non-ltr retrotransposons in mammals

Publications (1)

Publication Number Publication Date
ATE549410T1 true ATE549410T1 (de) 2012-03-15

Family

ID=39201850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08844540T ATE549410T1 (de) 2007-10-31 2008-10-30 Kontrollierte aktivierung von nicht-ltr- retrotransposonen bei säugetieren

Country Status (4)

Country Link
US (1) US9481892B2 (de)
EP (2) EP2055784A1 (de)
AT (1) ATE549410T1 (de)
WO (1) WO2009056321A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016030501A1 (en) * 2014-08-28 2016-03-03 Centre National De La Recherche Scientifique - Cnrs - Synthetic alu-retrotransposon vectors for gene therapy
MX2022002613A (es) * 2019-09-03 2022-06-02 Myeloid Therapeutics Inc Metodos y composiciones para la integracion del genoma.
CN115397987A (zh) * 2019-10-16 2022-11-25 阿卜杜拉国王科技大学 调节人l1反转录转座子rna的方法和用于其中的组合物
EP4337268A1 (de) * 2021-05-11 2024-03-20 Myeloid Therapeutics, Inc. Verfahren und zusammensetzungen zur genomischen integration
WO2023187431A1 (en) * 2022-04-01 2023-10-05 Szegedi Biológiai Kutatóközpont Measurement of somatic l1 retrotransposition activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8171087A (en) * 1986-10-27 1988-05-25 Whitehead Institute For Biomedical Research Gene amplification using retrotransposons
US20030121063A1 (en) * 1995-11-16 2003-06-26 The Trustees Of The University Of Pennsylvania Compositions and methods of use of mammalian retrotransposons
CA2474810A1 (en) 2002-01-31 2003-08-07 Dnavec Research Inc. Methods for retrotransposing long interspersed elements (lines)

Also Published As

Publication number Publication date
EP2205750B1 (de) 2012-03-14
US20110045591A1 (en) 2011-02-24
EP2205750A1 (de) 2010-07-14
EP2055784A1 (de) 2009-05-06
WO2009056321A1 (en) 2009-05-07
US9481892B2 (en) 2016-11-01

Similar Documents

Publication Publication Date Title
EP4269577A3 (de) Nukleobaseeditoren und deren verwendungen
CY1125029T1 (el) Τροποποιημενοι νουκλεοζιτες, νουκλεοτιδια, και νουκλεϊκα οξεα και χρησεις αυτων
CY1121657T1 (el) Μεθοδοι και συνθεσεις για κατευθυνομενη απο rna τροποποιηση dna στοχου και για κατευθυνομενη απο rna ρυθμιση της μεταγραφης
BR112018076190A2 (pt) ortólogos e sistemas crispr tipo vi
AU2017248555B2 (en) Closed nucleic acid structures
HRP20181833T1 (hr) Ekspresija proteina iz više nukleinskih kiselina
EP3252172A3 (de) Schnellhybridisierung zur anreicherung eines sequenzierungsziels der nächsten generation
WO2015160895A3 (en) Modified transposases for improved insertion sequence bias and increased dna input tolerance
EP3009511A3 (de) Neuartige crispr-enzyme und -systeme
WO2009126623A3 (en) Expression of heterologous sequences
BRPI0822218A2 (pt) Transferases e oxidorredutases, ácidos nucleicos que as codificam e métodos para fazê-las e usá-las.
CY1113713T1 (el) Ανοσοκατασταλτικα πολυπεπτιδια και νουκλεϊκα οξεα
EA201690529A1 (ru) Способы модификации клетки-хозяина
WO2011036564A3 (en) Hyperblebbing shigella strains
WO2009108217A3 (en) Compositions comprising k-ras sirna and methods of use
CO2018007568A2 (es) Composiciones y métodos para el direccionamiento eficaz de transgenes
WO2009114475A3 (en) Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use
WO2009039189A3 (en) Compositions comprising stat3 sirna and methods of use thereof
WO2009002440A3 (en) Compositions comprising human egfr-sirna and methods of use
ATE549410T1 (de) Kontrollierte aktivierung von nicht-ltr- retrotransposonen bei säugetieren
EP3141259A3 (de) Di-rückstände mit variabler wiederholung zum anzielen von nukleotiden
MX2009006681A (es) Composiciones y metodos para la expresion de acidos nucleicos.
MX370616B (es) Amplificacion de acidos nucleicos.
DK3467112T3 (da) Fremgangsmåder til transfektion af nukleinsyrer til levende celler
WO2009143371A3 (en) COMPOSITIONS COMPRISING mTOR SIRNA AND METHODS OF USE THEREOF